相似文献
1
AcrAB Efflux System: Expression and Contribution to Fluoroquinolone Resistance in Klebsiella spp.
Antimicrob Agents Chemother. 2002 Dec;46(12):3984-6. doi: 10.1128/AAC.46.12.3984-3986.2002.
2
Prevalence of two multidrug-resistant Klebsiella species in an Indian teaching hospital and adjoining community.
J Infect Public Health. 2014 Nov-Dec;7(6):496-507. doi: 10.1016/j.jiph.2014.05.002. Epub 2014 Jul 2.
3
RamA upregulates multidrug resistance efflux pumps AcrAB and OqxAB in Klebsiella pneumoniae.
Int J Antimicrob Agents. 2021 Feb;57(2):106251. doi: 10.1016/j.ijantimicag.2020.106251. Epub 2020 Nov 28.
4
Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe.
Eur J Clin Microbiol Infect Dis. 2000 Jan;19(1):64-8. doi: 10.1007/s100960050014.
5
Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin.
APMIS. 2003 Sep;111(9):857-66. doi: 10.1034/j.1600-0463.2003.1110904.x.
6
Antimicrobial Resistance of Clinical Isolates: Involvement of and Efflux Pumps.
Curr Mol Pharmacol. 2024;17(1):e310323215266. doi: 10.2174/1874467217666230331081434.
7
Molecular epidemiology of ciprofloxacin-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Taiwan.
Microb Drug Resist. 2012 Feb;18(1):52-8. doi: 10.1089/mdr.2011.0060. Epub 2011 Oct 24.
8
Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005.
Antimicrob Agents Chemother. 2007 Aug;51(8):3001-3. doi: 10.1128/AAC.00256-07. Epub 2007 May 25.
9
Phylogenetic relationships, virulence and antimicrobial resistance properties of Klebsiella sp. isolated from pet turtles in Korea.
Lett Appl Microbiol. 2020 Feb;70(2):71-78. doi: 10.1111/lam.13245. Epub 2019 Nov 28.
10
[Typing of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. strains and analysis of plasmid profiles].
Mikrobiyol Bul. 2009 Apr;43(2):183-94.
引用本文的文献
1
Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation.
JAC Antimicrob Resist. 2024 Aug 14;6(4):dlae127. doi: 10.1093/jacamr/dlae127. eCollection 2024 Aug.
2
Could traces of fluoroquinolones in food induce ciprofloxacin resistance in and ? An study in with important implications for maximum residue limits in food.
Microbiol Spectr. 2024 Jun 4;12(6):e0359523. doi: 10.1128/spectrum.03595-23. Epub 2024 Apr 30.
3
Biocide resistance in : a narrative review.
Infect Prev Pract. 2024 Mar 15;6(2):100360. doi: 10.1016/j.infpip.2024.100360. eCollection 2024 Jun.
4
Plant-Origin Components: New Players to Combat Antibiotic Resistance in .
Int J Mol Sci. 2024 Feb 10;25(4):2134. doi: 10.3390/ijms25042134.
5
Constitutive Activation of RpoH and the Addition of L-arabinose Influence Antibiotic Sensitivity of PHL628 .
Antibiotics (Basel). 2024 Feb 1;13(2):143. doi: 10.3390/antibiotics13020143.
6
Punicalagin, a pomegranate polyphenol sensitizes the activity of antibiotics against three MDR pathogens of the Enterobacteriaceae.
BMC Complement Med Ther. 2024 Feb 16;24(1):93. doi: 10.1186/s12906-024-04376-7.
7
Characteristics of antibiotic resistance mechanisms and genes of .
Open Med (Wars). 2023 May 12;18(1):20230707. doi: 10.1515/med-2023-0707. eCollection 2023.
8
Current State of Knowledge Regarding WHO Critical Priority Pathogens: Mechanisms of Resistance and Proposed Solutions through Candidates Such as Essential Oils.
Plants (Basel). 2022 Jul 6;11(14):1789. doi: 10.3390/plants11141789.
9
Profile of Bacteria with ARGs Among Real-World Samples from ICU Admission Patients with Pulmonary Infection Revealed by Metagenomic NGS.
Infect Drug Resist. 2021 Nov 27;14:4993-5004. doi: 10.2147/IDR.S335864. eCollection 2021.
10
The Characteristic of Virulence, Biofilm and Antibiotic Resistance of .
Int J Environ Res Public Health. 2020 Aug 28;17(17):6278. doi: 10.3390/ijerph17176278.
本文引用的文献
1
In vivo selection of a target/efflux double mutant of Pseudomonas aeruginosa by ciprofloxacin therapy.
J Antimicrob Chemother. 2001 Oct;48(4):553-5. doi: 10.1093/jac/48.4.553.
2
Phylogenetic diversity of Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates revealed by randomly amplified polymorphic DNA, gyrA and parC genes sequencing and automated ribotyping.
Int J Syst Evol Microbiol. 2001 May;51(Pt 3):915-924. doi: 10.1099/00207713-51-3-915.
3
High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA.
Antimicrob Agents Chemother. 2000 Dec;44(12):3441-3. doi: 10.1128/AAC.44.12.3441-3443.2000.
4
Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory season.
Antimicrob Agents Chemother. 2000 Feb;44(2):462-6. doi: 10.1128/AAC.44.2.462-466.2000.
5
Emergence and dissemination of quinolone-resistant Escherichia coli in the community.
Antimicrob Agents Chemother. 1999 Nov;43(11):2736-41. doi: 10.1128/AAC.43.11.2736.
6
Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.
Microb Drug Resist. 1998 Winter;4(4):257-61. doi: 10.1089/mdr.1998.4.257.
7
AcrA is a highly asymmetric protein capable of spanning the periplasm.
J Mol Biol. 1999 Jan 8;285(1):409-20. doi: 10.1006/jmbi.1998.2313.
8
gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae.
Antimicrob Agents Chemother. 1998 Oct;42(10):2661-7. doi: 10.1128/AAC.42.10.2661.
9
Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli.
J Antimicrob Chemother. 1998 Jan;41(1):111-4. doi: 10.1093/jac/41.1.111.
10
Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.
Antimicrob Agents Chemother. 1996 Oct;40(10):2380-6. doi: 10.1128/AAC.40.10.2380.
Zotero 插件